{
    "root": "4323fb1c-54a7-4648-bfe0-28fb4cb65f50",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "JANUMET",
        "suffix": {
            "text": "XR"
        }
    },
    "value": "20250325",
    "ingredients": [
        {
            "name": "SITAGLIPTIN PHOSPHATE",
            "code": "TS63EW8X6F"
        },
        {
            "name": "METFORMIN HYDROCHLORIDE",
            "code": "786Z46389E"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "HYPROMELLOSE 2208 (100000 MPA.S)",
            "code": "VM7F0B23ZI"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI"
        },
        {
            "name": "PROPYL GALLATE",
            "code": "8D4SNN7V92"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "KAOLIN",
            "code": "24H4NWX5CO"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "INDIGOTINDISULFONATE SODIUM",
            "code": "D3741U8K7L"
        },
        {
            "name": "ALUMINUM OXIDE",
            "code": "LMI26O6933"
        },
        {
            "name": "CARNAUBA WAX",
            "code": "R12CBM0EIZ"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "janumet\u00ae xr indicated adjunct diet exercise improve glycemic control adults type 2 diabetes mellitus .",
    "contraindications": "take janumet xr orally daily meal . patients taking two janumet xr tablets take tablets together . ( 2.1 ) individualize janumet xr basis patient \u2019 current regimen , effectiveness , tolerability . ( 2.1 ) maximum recommended daily dose 100 mg sitagliptin 2000 mg metformin hcl extended-release . ( 2.1 ) recommended starting dose patients currently treated metformin 100 mg sitagliptin 1000 mg metformin hcl daily , gradual dose escalation recommended reduce gastrointestinal effects due metformin . ( 2.1 ) starting dose patients already treated metformin provide sitagliptin dosed 100 mg dose metformin already taken daily . patients taking metformin hcl 850 mg twice daily 1000 mg twice daily , recommended starting dose janumet xr two 50 mg sitagliptin 1000 mg metformin hcl extended-release tablets daily . ( 2.1 ) maintain total daily dose sitagliptin metformin changing janumet janumet xr . ( 2.1 ) prior initiation , assess renal function estimated glomerular filtration rate ( egfr ) ( 2.2 ) patients egfr 30 ml/min/1.73 2 . discontinue egfr later falls 30 ml/min/1.73 2 . initiation recommended patients egfr 30 \u2013 45 ml/min/1.73 2 . assess risk/benefit continuing egfr falls 45 ml/min/1.73 2 . limit dose sitagliptin 50 mg daily egfr falls 45 ml/min/1.73 2 . janumet xr may need discontinued time , prior , iodinated contrast imaging procedures . ( 2.3 )",
    "warningsAndPrecautions": "tablets supplied follows : contents description supplied ndc 50 mg sitagliptin 500 mg metformin hcl extended-release light blue , bi-convex oval , film-coated tablets \u201c 78 \u201d debossed one side unit-of-use bottles 60 ndc 0006-0078-61 unit-of-use bottles 180 ndc 0006-0078-62 bulk bottles 1000 ndc 0006-0078-82 50 mg sitagliptin 1000 mg metformin hcl extended-release light green , bi-convex oval , film-coated tablets \u201c 80 \u201d debossed one side unit-of-use bottles 60 ndc 0006-0080-61 unit-of-use bottles 180 ndc 0006-0080-62 bulk bottles 1000 ndc 0006-0080-82 100 mg sitagliptin 1000 mg metformin hcl extended-release blue , bi-convex oval , film-coated tablets \u201c 81 \u201d debossed one side unit-of-use bottles 30 ndc 0006-0081-31 unit-of-use bottles 90 ndc 0006-0081-54 bulk bottles 1000 ndc 0006-0081-82",
    "adverseReactions": "janumet xr contraindicated patients : severe renal impairment ( egfr 30 ml/min/1.73 m2 ) [ ( 5.1 ) ] . acute chronic metabolic acidosis , including diabetic ketoacidosis . history serious hypersensitivity reaction janumet xr , sitagliptin , metformin anaphylaxis angioedema . [ ( 5.7 ) ; ( 6.2 ) . ]",
    "indications_original": "JANUMET\u00ae XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
    "contraindications_original": "Take JANUMET XR orally once daily with a meal. Patients taking two JANUMET XR tablets should take the tablets together. ( 2.1 ) Individualize the dosage of JANUMET XR on the basis of the patient\u2019s current regimen, effectiveness, and tolerability. ( 2.1 ) The maximum recommended daily dose is 100 mg of sitagliptin and 2000 mg of metformin HCl extended-release. ( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 100 mg sitagliptin and 1000 mg metformin HCl once daily, with gradual dose escalation recommended to reduce the gastrointestinal effects due to metformin. ( 2.1 ) The starting dose in patients already treated with metformin should provide sitagliptin dosed as 100 mg and the dose of metformin already being taken once daily. For patients taking metformin HCl 850 mg twice daily or 1000 mg twice daily, the recommended starting dose of JANUMET XR is two 50 mg sitagliptin and 1000 mg metformin HCl extended-release tablets once daily. ( 2.1 ) Maintain the same total daily dose of sitagliptin and metformin when changing between JANUMET and JANUMET XR. ( 2.1 ) Prior to initiation, assess renal function with estimated glomerular filtration rate (eGFR) ( 2.2 ) Do not use in patients with eGFR below 30 mL/min/1.73 m 2 . Discontinue if eGFR later falls below 30 mL/min/1.73 m 2 . Initiation is not recommended in patients with eGFR between 30 \u2013 45 mL/min/1.73 m 2 . Assess risk/benefit of continuing if eGFR falls below 45 mL/min/1.73 m 2 . Limit dose of sitagliptin to 50 mg once daily if eGFR falls below 45 mL/min/1.73 m 2 . JANUMET XR may need to be discontinued at time of, or prior to, iodinated contrast imaging procedures. ( 2.3 )",
    "warningsAndPrecautions_original": "Tablets supplied as follows:\n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           Contents\n                           Description\n\t\t\t\t\t\t\t\t\t\t\t\n                           How Supplied\n                           NDC\n                        \n                     \n                     \n                        \n                           \n\t\t\t\t\t\t\t\t\t\t\t\t50 mg sitagliptin and 500 mg metformin HCl extended-release\n\t\t\t\t\t\t\t\t\t\t\t\n                           light blue, bi-convex oval, film-coated tablets with \u201c78\u201d debossed on one side\n                           unit-of-use bottles of 60\n                           NDC 0006-0078-61\n                        \n                        \n                           unit-of-use bottles of 180\n                           NDC 0006-0078-62\n                        \n                        \n                           bulk bottles of 1000\n                           NDC 0006-0078-82\n                        \n                        \n                           \n\t\t\t\t\t\t\t\t\t\t\t\t50 mg sitagliptin and 1000 mg metformin HCl extended-release\n\t\t\t\t\t\t\t\t\t\t\t\n                           light green, bi-convex oval, film-coated tablets with \u201c80\u201d debossed on one side\n                           unit-of-use bottles of 60\n                           NDC 0006-0080-61\n                        \n                        \n                           unit-of-use bottles of 180\n                           NDC 0006-0080-62\n                        \n                        \n                           bulk bottles of 1000\n                           NDC 0006-0080-82\n                        \n                        \n                           \n\t\t\t\t\t\t\t\t\t\t\t\t100 mg sitagliptin and 1000 mg metformin HCl extended-release\n\t\t\t\t\t\t\t\t\t\t\t\n                           blue, bi-convex oval, film-coated tablets with \u201c81\u201d debossed on one side\n                           unit-of-use bottles of 30\n                           NDC 0006-0081-31\n                        \n                        \n                           unit-of-use bottles of 90\n                           NDC 0006-0081-54\n                        \n                        \n                           bulk bottles of 1000\n                           NDC 0006-0081-82",
    "adverseReactions_original": "JANUMET XR is contraindicated in patients with:\n                  \n                     Severe renal impairment (eGFR below 30 mL/min/1.73 m2) [see Warnings and Precautions (5.1)].\n                     Acute or chronic metabolic acidosis, including diabetic ketoacidosis.\n                     History of a serious hypersensitivity reaction to JANUMET XR, sitagliptin, or metformin such as anaphylaxis or angioedema. [See Warnings and Precautions (5.7); Adverse Reactions (6.2).\n                        ]"
}